These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 7726905)

  • 1. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers.
    Behrens RH; Roberts JA
    BMJ; 1994 Oct; 309(6959):918-22. PubMed ID: 7726905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: a prospective, questionnaire-based analysis.
    Pavli A; Smeti P; Spilioti A; Silvestros C; Katerelos P; Maltezou HC
    Travel Med Infect Dis; 2014; 12(6 Pt B):764-70. PubMed ID: 24957561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against hepatitis A for travellers. All relevant costs and consequences should be measured.
    Hardie R
    BMJ; 1995 Jan; 310(6971):61-2. PubMed ID: 7827577
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination against hepatitis A for travellers. Will alter the dynamics of transmission in Britain.
    Neal K
    BMJ; 1995 Jan; 310(6971):61. PubMed ID: 7827576
    [No Abstract]   [Full Text] [Related]  

  • 6. Routine and recommended vaccinations for travellers.
    Duszczyk E; Talarek E
    Int Marit Health; 2008; 59(1-4):116-23. PubMed ID: 19227745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel prophylaxis. Assumptions were confusing.
    Van Damme P; Van Doorslaer E; Tormans G; Beutels P
    BMJ; 1995 Feb; 310(6976):402. PubMed ID: 7866237
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis and typhoid vaccine: killing two birds with one stone.
    Tucker R
    Community Nurse; 1999 Nov; 5(10):41-2. PubMed ID: 10732550
    [No Abstract]   [Full Text] [Related]  

  • 10. Compliance of Austrian tourists with prophylactic measures.
    Kollaritsch H; Wiedermann G
    Eur J Epidemiol; 1992 Mar; 8(2):243-51. PubMed ID: 1644143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A, typhoid and malaria among travelers--surveillance data from Québec (Canada).
    Provost S; Gagnon S; Lonergan G; Bui YG; Labbé AC
    J Travel Med; 2006; 13(4):219-26. PubMed ID: 16884404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of vaccination against hepatitis A for frequent travellers.
    Fenn P; McGuire A; Gray A
    J Infect; 1998 Jan; 36(1):17-22. PubMed ID: 9515663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Costs of hepatitis A prophylaxis in travelers].
    Zaaijer HL; Lelie PN
    Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of vaccination against hepatitis A in travellers.
    Van Doorslaer E; Tormans G; Van Damme P
    J Med Virol; 1994 Dec; 44(4):463-9. PubMed ID: 7897383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
    Conrad DA; Jenson HB
    Postgrad Med; 1996 Oct; 100(4):113-8, 121-5, 127. PubMed ID: 8858086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting travellers from hepatitis A.
    Webster G; Barnes E; Dusheiko G; Franklin I
    BMJ; 2001 May; 322(7296):1194-5. PubMed ID: 11358758
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa.
    Widmer LL; Blank PR; Van Herck K; Hatz C; Schlagenhauf P
    BMC Infect Dis; 2010 Sep; 10():279. PubMed ID: 20860809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating investments in typhoid vaccines in two slums in Kolkata, India.
    Cook J; Sur D; Clemens J; Whittington D
    J Health Popul Nutr; 2009 Dec; 27(6):711-24. PubMed ID: 20099754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
    Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
    J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V; Vergidis PI; Bliziotis I; Falagas ME
    Clin Microbiol Infect; 2004 Aug; 10(8):681-3. PubMed ID: 15301670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.